 Sahyadri Industries Ltd Q2 FY2025-26 net profit declines QoQ to Rs. 2.71 crores
Sahyadri Industries Ltd Q2 FY2025-26 net profit declines QoQ to Rs. 2.71 crores Gujarat Containers Ltd Q2 FY2026 PAT lower at Rs. 1.35 crore
Gujarat Containers Ltd Q2 FY2026 PAT lower at Rs. 1.35 crore Northern Arc Capital Ltd Q2FY26 consolidated net profit at Rs. 91.70 crores
Northern Arc Capital Ltd Q2FY26 consolidated net profit at Rs. 91.70 crores Bharat Petroleum Corporation Ltd consolidated Q2FY26 net profit slips QoQ to Rs. 6191.49 crores
Bharat Petroleum Corporation Ltd consolidated Q2FY26 net profit slips QoQ to Rs. 6191.49 crores Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati
Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati 
              UniParts India (UPI), incorporated in 1994, is a leading supplier of systems and components for the off-highway market in the agriculture and construction, forestry and mining and aftermarket sectors. It has presence in over 25 countries. UPI has 6 manufacturing facilities (5 in India, 1 in USA)
- Its key product includes 3-point linkage systems (3PL) & precision machined parts (PMP) which together constitute over 90% of its sales. It also manufactures adjacent products like Hydraulics, PTO & fabrications.
- In terms of value, as of FY22, UPI has an estimated 16.7% market share of the global 3PL market and an estimated 5.9% market share in the global PMP market in the CFM (construction, forestry and mining) sector
Key triggers / Highlights
- Leading market presence in critical vehicle systems & components space catering to global off-highway segment (tractors, construction equipment)
- Engineering driven, vertically integrated precision solutions provider
- Strategically located manufacturing & warehousing units across the globe to ensure seamless delivery of its products that offer scale & flexibility
- Long term relationship with key customers including global OEM's with outside India sales constituting ~80%+ of its sales
- Healthy financials: Double digit EBITDA margin (~22%) and Return ratios profile (RoCE >25%) with Debt: Equity at 0.2x as of FY22
For details, click on the link below: Link to the report